TMDX (TransMedics Group) Institutional Ownership: 116.08% (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMDX TransMedics Group Inc TMDX
69 GF Score
Price $71.20
GF Value $169.98
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is TransMedics Group Institutional Ownership?

TransMedics Group TMDX -4.16% 69 Institutional Ownership is 116.08% as of Jul. 22, 2026. GuruFocus rates TMDX with a GF Score™ of 69/100 and a GF Value™ of $169.98 (Possible Value Trap). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TransMedics Group's institutional ownership is 116.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TransMedics Group's Insider Ownership is 1.88%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TransMedics Group's Float Percentage Of Total Shares Outstanding is 64.12%.

TransMedics Group Institutional Ownership Historical Data

* Premium members only.

The historical data trend for TransMedics Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransMedics Group Institutional Ownership Chart

TransMedics Group Historical Data

The historical data trend for TransMedics Group can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 76.00 75.01 75.77 77.02 76.67 77.67 77.77 77.22 76.50 75.36
TMDX
69GF Score
TransMedics Group Inc TMDX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TransMedics Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 116.08% mean?
TransMedics Group (TMDX) has a Institutional Ownership of 116.08% as of Jul. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TransMedics Group and its competitors.
Is TransMedics Group's Institutional Ownership too high?
TransMedics Group's current Institutional Ownership is 116.08%. Overall, TransMedics Group has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Institutional Ownership compare to AXGN and BFLY?
TransMedics Group's Institutional Ownership of 116.08% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TransMedics Group and its competitors. TransMedics Group's current Institutional Ownership is 116.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
Based on GuruFocus' analysis, TransMedics Group (TMDX) is currently considered Possible Value Trap. The stock's GF Value™ is $169.98, compared to a current price of $71.20 — trading 58.1% below its estimated fair value. The current Institutional Ownership is 116.08%. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For TransMedics Group (TMDX), the current Institutional Ownership is 116.08% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TransMedics Group (TMDX) Overvalued in 2026?

Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued. The current stock price of $71.20 is trading 58.1% below its estimated GF Value™ of $169.98. GuruFocus considers TransMedics Group to be Possible Value Trap.

Key valuation signals for TMDX:

  • Institutional Ownership: 116.08%
  • GF Value™: $169.98 vs. price of $71.20 (58.1% below fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TransMedics Group Business Description

Address 200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score

Get the complete analysis for TMDX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.20
Price
$169.98
GF Value